Literature DB >> 7033670

Orthotopic transplantation of the baboon heart after 20 to 24 hours' preservation by continuous hypothermic perfusion with an oxygenated hyperosmolar solution.

W Wicomb, D K Cooper, J Hassoulas, A G Rose, C N Barnard.   

Abstract

Baboon hearts were rapidly excised after being flushed with 500 ml of cardioplegic solution at 4 degrees C and then immersed in cold 4 degrees C saline or cardioplegic solution for 2 minutes. The hearts were then perfused at 8 to 10 cm H2O pressure for 20 to 24 hours under refrigeration with a hyperosmolar clear fluid maintain perfusate at 6 to 8 degrees C, through which 95% oxygen and 5% carbon dioxide were continually bubbled to maintain the perfusate pH between 7.2 and 7.4. Myocardial temperature remained at approximately 6 to 8 degrees C. The hearts were then orthotopically transplanted into recipient baboons matched for size and AB blood group. Two groups (A and B) were studied, differing significantly only with respect to the constitution of the cardioplegic solution and perfusate used. The cardioplegic agent used in Group B contained a higher concentration of magnesium than that used in Group A and included the calcium antagonist verapamil. Perfusate B had higher osmolality than perfusate A, largely due to the inclusion of sucrose. A preliminary group of 10 baboons in Group A received no immunosuppression. Five of the remaining six immunosuppressed baboons in this group survived more than 48 hours to rejection or until killed at 2 to 29 days. All six of the baboons in Group B survived to rejection between 6 and 33 days, with mean survival 19.5 days. Cardiac catheterization was performed in six surviving baboons (Group A, four; Group B, two) between postoperative days 6 and 10 and showed good hemodynamic function. Histologic examination of hearts after death has shown only minor ischemic changes in those hearts which functioned well.

Entities:  

Mesh:

Year:  1982        PMID: 7033670

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  Evolution of the Texas Heart Institute Distant Organ Procurement Program.

Authors:  I J Reece; G A Painvin; O U Okereke; L B Chandler; T W Krudewig; S R Igo; D A Cooley; O H Frazier
Journal:  Tex Heart Inst J       Date:  1984-03

2.  A cardiac myocyte culture system as an in vitro experimental model for the evaluation of hypothermic preservation.

Authors:  H Orita; M Fukasawa; S Hirooka; K Fukui; M Kohi; M Washio
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  In vitro protective effects of nicorandil on hypothermic injury to immature cardiac myocytes: comparison with nitroglycerin.

Authors:  H Orita; M Fukasawa; S Hirooka; K Fukui; M Kohi; M Washio
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

4.  Electron microscopic changes and edema after nine hours' perfusion of isolated canine hearts.

Authors:  R Silber; B Sauer; P Eigel; H A Henrich; O Elert
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

5.  An in vitro evaluation of prostaglandin E1 and I2 on hypothermic injury to immature myocytes.

Authors:  H Orita; M Fukasawa; K Inui; S Hirooka; H Uchino; K Fukui; M Kohi; M Washio
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  In vitro evaluation of diltiazem on hypothermic injury to immature myocytes.

Authors:  H Orita; M Fukasawa; S Hirooka; H Uchino; K Fukui; M Kohi; M Washio
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

7.  In vitro evaluation of phosphate, bicarbonate, and Hepes buffered storage solutions on hypothermic injury to immature myocytes.

Authors:  H Orita; M Fukasawa; S Hirooka; H Uchino; K Fukui; M Washio
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

8.  Accelerated myocardial metabolic and functional recovery with terminal nicorandil-Mg cardioplegia in heart transplantation.

Authors:  H Orita; T Shimanuki; M Fukasawa; H Abe; S Kuraoka; S Hirooka; M Washio
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

9.  An innovative cold storage system for donor heart transportation-lessons learned from the first experience in Switzerland.

Authors:  Martin O Schmiady; Tim Graf; Ahmed Ouda; Raed Aser; Andreas J Flammer; Paul R Vogt; Markus J Wilhelm
Journal:  J Thorac Dis       Date:  2021-12       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.